Navigation Links
Meteosat Third Generation takes a step forward
Date:2/23/2010

Since the launch of the first Meteosat in 1977, 33 years of imagery combined with increasing computer power have given meteorologists the tools to improve weather forecasting, with direct benefits for us.

Numerical weather prediction is improving with data from operational satellites, like Meteosat Second Generation (MSG). Today, thousands of daily measurements are the basis for numerical forecasts, making use of the world's most powerful computers. The MSG satellites are expected to provide operational services at least until 2015.

In order to have follow-up geostationary missions, ESA and the European Organisation for the Exploitation of Meteorological Satellites (EUMETSAT) plan the Meteosat Third Generation (MTG) satellite system. Intended for launch in 2015, MTG will provide a significant improvement over the capabilities of the current Meteosat satellites.

The finalisation of the selection process for the contract to build the MTG satellites is still under way. After careful evaluation of proposals received by industry, the Tender Evaluation Board (TEB) has made a recommendation to ESA's Director General. The Director General has asked the TEB for some clarifications on the detailed report.

These clarifications will be provided at the beginning of March. The announcement of the company with which negotiations will be initiated will, therefore, take place in early March in order to allow the EUMETSAT special Council, planned on 15 March, to approve the MTG Programme Proposal.

Weather satellites allow us to monitor large areas of the globe, compensating for gaps in the terrestrial or sea-surface meteorology data-gathering network. The wide-area view provided by satellites can frame an entire weather system in a single optical or infrared image. MTG will be a European operational geostationary meteorological satellite system and is set to revolutionise weather forecasting and environmental monitoring.


'/>"/>

Contact: Robert Meisner
robert.meisner@esa.int
39-069-418-0874
European Space Agency
Source:Eurekalert

Page: 1

Related biology news :

1. Study reveals new details on the dangers of third-hand smoke
2. MODA Announces Availability of Third Generation Mobile Data Acquisition Platform
3. SCM Microsystems Reports Third Quarter 2009 Results
4. Quest Diagnostics Reports Strong Performance in Third Quarter 2009
5. Aware, Inc. Reports Third Quarter 2009 Financial Results
6. Aware, Inc. Reports Third Quarter 2009 Financial Results
7. Quest Diagnostics Reports Strong Performance in Third Quarter 2009
8. Discovery to aid in future treatments of third-world parasites
9. CWRU receives $5 million from Ohio Third Frontier Commission
10. Results of the third school nutrition dietary assessment study published
11. Orchid Cellmark Reports Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... , Jan. 12, 2017  New research undertaken by ... of the future.  1,000 participants were simply asked which office ... which we may consider standard issue.  Insights on what ... were also gathered from futurists and industry leaders including ... James Canton .  Some of these ...
(Date:1/6/2017)... JOLLA, Calif. , Jan. 6, 2017 /PRNewswire/ ... 1 safety studies in healthy volunteers of a ... intended to treat acute pancreatitis. ... is typically a mild disorder, but can be ... organ failure and sepsis, where extended hospital stays, ...
(Date:1/4/2017)... VEGAS , Jan. 4, 2017  CES ... performance biometric sensor technology, today announced the launch ... sensor systems, the highly-accurate biometric sensor modules ... biometric technology, experience and expertise. The two ... Benchmark designed specifically for hearables, and Benchmark BW2.0, ...
Breaking Biology News(10 mins):
(Date:1/17/2017)... Boston, MA (PRWEB) , ... January 17, 2017 ... ... of the completely re-engineered Drug Safety Technology Consortium™ (SafeTEC™), $3 million in investment ... be validating these new tools and assays, and their applicability in drug safety ...
(Date:1/17/2017)... 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: ... initiated a global Phase 2b induction study in ... targets alpha4beta7 integrin. The aim of this randomized, ... the safety/tolerability and efficacy of PTG-100 in approximately ... severe active disease. "We are ...
(Date:1/16/2017)...   Valentin A. Pavlov, PhD , associate investigator, ... CEO of The Feinstein Institute for Medical Research ... the nervous system regulates the immune system, which will ... devices to treat disease and injury. The analysis ... The paper examines various studies which further define ...
(Date:1/14/2017)... ... 14, 2017 , ... Seattle-based Phase Genomics has announced the ... researchers around the globe. Long considered a “holy grail” in biological research, ... of scientific questions. The announcement was made today at the Plant & ...
Breaking Biology Technology: